mhurhangee/ep-ind-claims huggingface dataset:
Method for controlling a technical system by means of a trained and/or trainable control model (SM, SM1, SM2), wherein, by way of a processor (PROC), a) a data container (DC, DC1, DC2) is received in which a control model (SM, SM1, SM2) having a training structure and model type information (MTI, MTI1, MTI2) are encoded for all model types, b) one of a plurality of model type-specific execution modules (EM1, EM2, EM3) is selected for the technical system depending on the model type information (MTI, MTI1, MTI2), wherein the execution modules (EM1, EM2, EM3) serve to execute, initialize and/or evaluate trained and/or trainable control models on the or for the technical system, c) operating data channels of the technical system are assigned to input channels of the control model (SM, SM1, SM2) depending on the model type information (MTI, MTI1, MTI2), d) operating data of the technical system are acquired via a respective operating data channel and are transmitted to the control model (SM, SM1, SM2) via an input channel assigned to this operating data channel, e) the control model (SM, SM1, SM2) is executed by way of the selected execution module (EM1, EM2), wherein control data are derived from the transmitted operating data according to the training structure, and f) the control data are output in order to control the technical system. a) a data container (DC, DC1, DC2) is received in which a control model (SM, SM1, SM2) having a training structure and model type information (MTI, MTI1, MTI2) are encoded for all model types, b) one of a plurality of model type-specific execution modules (EM1, EM2, EM3) is selected for the technical system depending on the model type information (MTI, MTI1, MTI2), wherein the execution modules (EM1, EM2, EM3) serve to execute, initialize and/or evaluate trained and/or trainable control models on the or for the technical system, c) operating data channels of the technical system are assigned to input channels of the control model (SM, SM1, SM2) depending on the model type information (MTI, MTI1, MTI2), d) operating data of the technical system are acquired via a respective operating data channel and are transmitted to the control model (SM, SM1, SM2) via an input channel assigned to this operating data channel, e) the control model (SM, SM1, SM2) is executed by way of the selected execution module (EM1, EM2), wherein control data are derived from the transmitted operating data according to the training structure, and f) the control data are output in order to control the technical system.
Combustion apparatus comprising: a burner for burning a fuel within a furnace in a theoretical air ratio or less, and a plurality of air ports arranged downstream of the burner and injecting combustion air for the shortfall in the burner into the furnace, wherein inhibiting gas supply means for supplying a nitrogen oxide (NOx) generation inhibiting gas constituted by at least one gas selected from the combustion exhaust gas, a mixed gas of the combustion exhaust gas and air, and low temperature air, inhibiting nitrogen oxides (NOx) from being generated are provided in the mixing region formed within the furnace by both of the combustion gas generated by burning the fuel by means of the burner and the combustion air injected from the air ports or near said mixing region, wherein said plurality of air ports are placed along a width direction of the furnace, characterized in that each of the air ports is provided with said inhibiting gas supply means and with flow rate regulating means for regulating the flow rate of the inhibiting gas, wherein said flow rate regulating means is configured so that the inhibiting gas is supplied more to an air port close to the furnace center portion than to an air port close to a furnace side wall in the plurality of air ports. a burner for burning a fuel within a furnace in a theoretical air ratio or less, and a plurality of air ports arranged downstream of the burner and injecting combustion air for the shortfall in the burner into the furnace, wherein inhibiting gas supply means for supplying a nitrogen oxide (NOx) generation inhibiting gas constituted by at least one gas selected from the combustion exhaust gas, a mixed gas of the combustion exhaust gas and air, and low temperature air, inhibiting nitrogen oxides (NOx) from being generated are provided in the mixing region formed within the furnace by both of the combustion gas generated by burning the fuel by means of the burner and the combustion air injected from the air ports or near said mixing region, wherein said plurality of air ports are placed along a width direction of the furnace, characterized in that each of the air ports is provided with said inhibiting gas supply means and with flow rate regulating means for regulating the flow rate of the inhibiting gas, wherein said flow rate regulating means is configured so that the inhibiting gas is supplied more to an air port close to the furnace center portion than to an air port close to a furnace side wall in the plurality of air ports.
A base station device for receiving the signals transmitted from a plurality of terminal devices (A80a, A80b), the base station device is configured to: receive signals including a first DFT-S-OFDM signal and a second DFT-S-OFDM signal, the first frequency spread signals are allocated onto a first set of subcarriers consisting of a plurality of continuous subcarriers, the second frequency spread signals are allocated onto a second set of subcarriers consisting of a plurality of continuous subcarriers, wherein a portion of the second set of subcarriers overlaps in frequency with at least a portion of the first set of subcarriers in a time frame, remove the second DFT-S-OFDM signal transmitted by said overlapping subcarriers in frequency from the received signals; and demodulate information included in the first DFT-S-OFDM signal; wherein each of the first set of subcarriers and the second set of subcarriers used by one of the plurality of terminal devices (A80a, A80b) or another one of the plurality of terminal devices (A80a, A80b) is independently determined when the first set of subcarriers and the second set of subcarriers are allocated to the one of the plurality of terminal devices (A80a, A80b) and the other one of the plurality of terminal devices (A80a, A80b), respectively. receive signals including a first DFT-S-OFDM signal and a second DFT-S-OFDM signal, the first frequency spread signals are allocated onto a first set of subcarriers consisting of a plurality of continuous subcarriers, the second frequency spread signals are allocated onto a second set of subcarriers consisting of a plurality of continuous subcarriers, wherein a portion of the second set of subcarriers overlaps in frequency with at least a portion of the first set of subcarriers in a time frame, remove the second DFT-S-OFDM signal transmitted by said overlapping subcarriers in frequency from the received signals; and demodulate information included in the first DFT-S-OFDM signal; wherein each of the first set of subcarriers and the second set of subcarriers used by one of the plurality of terminal devices (A80a, A80b) or another one of the plurality of terminal devices (A80a, A80b) is independently determined when the first set of subcarriers and the second set of subcarriers are allocated to the one of the plurality of terminal devices (A80a, A80b) and the other one of the plurality of terminal devices (A80a, A80b), respectively.
A method for generating a display of an industrial installation including information about an event or an alarm, the method comprising displaying a holographic image comprising a view of said industrial installation, wherein the view comprises one or more points in three dimensional space; and mapping the one or more points to a corresponding point or position in said industrial installation, characterized in that the method comprises the steps of detecting, in response to placing by a user a pointer object near to one of the one or more points in the holographic image, a change in a transmission, reflection, refraction or scattering of one or more rays of light making up the holographic image, and mapping the changed or disrupted one or more rays of light to at least one point in three dimensional space and subsequently to one or more points in three dimensional space in a computer implemented 3-D model of said industrial installation. displaying a holographic image comprising a view of said industrial installation, wherein the view comprises one or more points in three dimensional space; and mapping the one or more points to a corresponding point or position in said industrial installation, characterized in that the method comprises the steps of detecting, in response to placing by a user a pointer object near to one of the one or more points in the holographic image, a change in a transmission, reflection, refraction or scattering of one or more rays of light making up the holographic image, and mapping the changed or disrupted one or more rays of light to at least one point in three dimensional space and subsequently to one or more points in three dimensional space in a computer implemented 3-D model of said industrial installation.
A method for producing a water-absorbent resin comprising performing a reversed-phase suspension polymerization of a water-soluble ethylenically unsaturated monomer in a petroleum hydrocarbon dispersion medium by using a surfactant, a pouring rate upon dispersing an aqueous solution of the water-soluble ethylenically unsaturated monomer in the dispersion medium, is satisfied with the following conditions: (a) an addition rate V i of the aqueous solution is 0.30 [min -1] or less upon dispersing an aqueous solution of the water-soluble ethylenically unsaturated monomer in the dispersion medium, wherein the addition rate V i is defined by Equation: V i = F i × A i / T wherein i: Nozzle number (1 to n), n: Number of nozzles(1≤n≤10), V i: Addition rate [min -1], F i: Average linear flow rate from nozzle [m/min], A i: Cross-section area of nozzle [m 2], and T: Total amount [m 3] of the aqueous monomer solution charged in a polymerization reaction tank; and (b) a total addition rate V total of the aqueous monomer solution of the water-soluble ethylenically unsaturated monomer charged in the polymerization reaction tank, is 0.04 [min -1] or more, wherein the total addition rate V total is defined by the following Equation: V total = ∑ V i i = 1 to n wherein V total: Total addition rate [min -1], V i: Addition rate of each nozzle [min -1], and i and n are as defined in Equation, incidentally V total = V 1 when the polymerization equipment has one nozzle (n=1). (a) an addition rate V i of the aqueous solution is 0.30 [min -1] or less upon dispersing an aqueous solution of the water-soluble ethylenically unsaturated monomer in the dispersion medium, wherein the addition rate V i is defined by Equation: V i = F i × A i / T wherein i: Nozzle number (1 to n), n: Number of nozzles(1≤n≤10), V i: Addition rate [min -1], F i: Average linear flow rate from nozzle [m/min], A i: Cross-section area of nozzle [m 2], and T: Total amount [m 3] of the aqueous monomer solution charged in a polymerization reaction tank; and (b) a total addition rate V total of the aqueous monomer solution of the water-soluble ethylenically unsaturated monomer charged in the polymerization reaction tank, is 0.04 [min -1] or more, wherein the total addition rate V total is defined by the following Equation: V total = ∑ V i i = 1 to n wherein V total: Total addition rate [min -1], V i: Addition rate of each nozzle [min -1], and i and n are as defined in Equation, incidentally V total = V 1 when the polymerization equipment has one nozzle (n=1).
The compound 6-(3-methoxycarbonyl phenyl) amino-2,4 (1H, 3H)-pyrimidinedione with the sum formula of the compound: C 12 H 11 N 3 O 4 and with the general structural formula of the compound:
A method for determining potential efficacy of an anti-cancer agent for a specific cancer in a subject, the method comprising isolating circulating tumor cells (CTCs) from a blood sample from the subject; converting CTC-derived RNA into cDNA; encapsulating the cDNA into individual droplets; amplifying the cDNA in each droplet in the presence of a reporter group configured to bind specifically to cDNA from CTCs and not to cDNA from other cells in the blood; and determining which of a series of lineage markers are expressed in the CTCs in the blood sample, wherein an expression level of a specific one or more lineage markers is predictive of progression-free survival and overall survival for a specific anti-cancer treatment regimen, wherein the subject has hormone receptor-positive breast cancer and: if the subject's specific lineage markers assayed at three to four weeks after treatment with a drug targeting the estrogen-signaling pathway include an elevated level of PIP, SERPINA3, AGR2, SCGB2A1, EFHD1, and WFDC2 genes above a background noise level determined by evaluation of healthy donors without cancer, then the method predicts that the patient will not improve if treated only with a drug that targets the estrogen-signaling pathway. isolating circulating tumor cells (CTCs) from a blood sample from the subject; converting CTC-derived RNA into cDNA; encapsulating the cDNA into individual droplets; amplifying the cDNA in each droplet in the presence of a reporter group configured to bind specifically to cDNA from CTCs and not to cDNA from other cells in the blood; and determining which of a series of lineage markers are expressed in the CTCs in the blood sample, wherein an expression level of a specific one or more lineage markers is predictive of progression-free survival and overall survival for a specific anti-cancer treatment regimen, wherein the subject has hormone receptor-positive breast cancer and: if the subject's specific lineage markers assayed at three to four weeks after treatment with a drug targeting the estrogen-signaling pathway include an elevated level of PIP, SERPINA3, AGR2, SCGB2A1, EFHD1, and WFDC2 genes above a background noise level determined by evaluation of healthy donors without cancer, then the method predicts that the patient will not improve if treated only with a drug that targets the estrogen-signaling pathway. if the subject's specific lineage markers assayed at three to four weeks after treatment with a drug targeting the estrogen-signaling pathway include an elevated level of PIP, SERPINA3, AGR2, SCGB2A1, EFHD1, and WFDC2 genes above a background noise level determined by evaluation of healthy donors without cancer, then the method predicts that the patient will not improve if treated only with a drug that targets the estrogen-signaling pathway.
A software information organization method, comprising: - loading first software, which comprises a code, data, resources and documents; - obtaining first information from the code of the first software, and generating a first knowledge graph based on the first information; - obtaining second information from the data, resources and documents of the first software, and generating a second knowledge graph based on the second information; - combining the first knowledge graph and the second knowledge graph into a third knowledge graph; - storing the third knowledge graph in a knowledge graph library; - receiving a user instruction to search for software similar to a second software; - loading the second software, which comprises a code, data, resources and documents; - obtaining third information from the code of the second software, and generating a fourth knowledge graph based on the third information; - obtaining fourth information from the data, resources and documents of the second software, and generating a fifth knowledge graph based on the fourth information; - comparing the fourth knowledge graph and the fifth knowledge graph with one or more knowledge graphs stored in the knowledge graph library, to determine software similar to the second software. - loading first software, which comprises a code, data, resources and documents; - obtaining first information from the code of the first software, and generating a first knowledge graph based on the first information; - obtaining second information from the data, resources and documents of the first software, and generating a second knowledge graph based on the second information; - combining the first knowledge graph and the second knowledge graph into a third knowledge graph; - storing the third knowledge graph in a knowledge graph library; - receiving a user instruction to search for software similar to a second software; - loading the second software, which comprises a code, data, resources and documents; - obtaining third information from the code of the second software, and generating a fourth knowledge graph based on the third information; - obtaining fourth information from the data, resources and documents of the second software, and generating a fifth knowledge graph based on the fourth information; - comparing the fourth knowledge graph and the fifth knowledge graph with one or more knowledge graphs stored in the knowledge graph library, to determine software similar to the second software.
A method for testing the effect of a production step or production steps or the effectiveness of a purification step or purification steps on the presence or the nature of pro-inflammatory molecules in glucose polymers or hydrolysates thereof, comprising: a) providing glucose polymers or hydrolysates thereof; b) detecting or assaying the pro-inflammatory molecules in the glucose polymers or hydrolysates thereof provided in step a); c) carrying out the production or purification step or steps on the glucose polymers or hydrolysates thereof provided in step a); d) detecting or assaying the pro-inflammatory molecules in the glucose polymers or hydrolysates thereof obtained after step c); e) determining the effectiveness or the impact of step c) on the presence or the nature of the pro-inflammatory molecules for glucose polymers or hydrolysates thereof detected or assayed at steps b) and d), a decrease of the amount of pro-inflammatory molecules or some of these pro-inflammatory molecules being indicative of the efficie,cy of step c) for decontaminating glucose polymers or hydrolysates thereof; in which the step for detecting or assaying the pro-inflammatory molecules in the glucose polymers or hydrolysates thereof comprises an in vitro inflammatory response test using a cell line expressing the TLR2 receptor (Toll Like Receptor 2) and a reporter gene the transcription of which is under the direct control of the TLR2 signaling pathway, the pro-inflammatory molecules being detected or assayed by measuring the activity or the signal of the reporter gene. a) providing glucose polymers or hydrolysates thereof; b) detecting or assaying the pro-inflammatory molecules in the glucose polymers or hydrolysates thereof provided in step a); c) carrying out the production or purification step or steps on the glucose polymers or hydrolysates thereof provided in step a); d) detecting or assaying the pro-inflammatory molecules in the glucose polymers or hydrolysates thereof obtained after step c); e) determining the effectiveness or the impact of step c) on the presence or the nature of the pro-inflammatory molecules for glucose polymers or hydrolysates thereof detected or assayed at steps b) and d), a decrease of the amount of pro-inflammatory molecules or some of these pro-inflammatory molecules being indicative of the efficie,cy of step c) for decontaminating glucose polymers or hydrolysates thereof;
A hydroxyethyl starch, as therapeutically active compound for use in the treatment of cancer wherein the treatment is characterized as reducing the growth rate of tumors in a combination therapy with one or more compounds selected from the group consisting of cytostatica, biologicals with anti-cancer activity and hormons with anti-cancer activity wherein the combination therapy is the administration of a therapeutically effective amount of HES and a separate administration of a therapeutically effective amount of one or more compounds selected from the group consisting of cytostatica, biologicals with anti-cancer activity and hormons with anti-cancer activity.
Drive unit for a revolving door which is attached above the door rotating about the central axis of the revolving door, comprising an upper bearing of the part of the revolving door rotating about the central axis in which a bearing of the drive unit which is close to the ceiling is located to receive the central middle column and further comprising a rotating part of the drive unit, a fixed part of the drive unit and an electric motor, the rotor of which is arranged coaxially to the central axis and is connected without a gear to the doors rotating about the central axis, wherein to receive axial clearance of the middle column, the bearing of the middle column which is close to the ceiling is designed to be displaceable in axial direction (23, 32) of the middle column, or in that the middle column is designed to be displaceable with respect to the bearing which is close to the ceiling, characterised in that the bearing which is close to the ceiling is designed as a roller bearing, the inner bearing ring of which is designed to be displaceable in axial direction with respect to an inner shoulder of the rotating part of the drive unit and in that the inner circumference of the inner bearing ring is designed as a loose seat with respect to the outer circumference of the inner shoulder of the rotating part of the drive unit.
Strip washing method for washing a textile strip, textile strips or textile strand formations in a sink, - wherein a supply device initially supplies the strip or the parallel strips to the sink, - and wherein the strip or the parallel strips are deflected in the sink by a deflector roll, characterized in that a washing fluid is transported through the strip or the parallel strips by means of at least one washing roll (20.1, 20.2) that is arranged in the sink with a fluid-permeable outer wall, around which washing roll (20.1, 20.2) the strips at least partially circulate or around which the strip circulates several times, wherein the washing roll (20.1, 20.2) has a pulsation roll (24, 24') arranged within the outer wall and coaxial to the outer wall and rotating independently of the outer wall, wherein the pulsation roll (24, 24') has at least one blade along its outer surrounding surface, wherein the blade is formed so that a relative movement of the pulsation roll toward the outer wall permits transport of a washing fluid through the outer wall, wherein the washing roll (20.1, 20.2) is fly-mounted in one of the side walls of the sink to form a revision opening, and the washing roll is removed through the revision opening for reconfiguration and maintenance. - wherein a supply device initially supplies the strip or the parallel strips to the sink, - and wherein the strip or the parallel strips are deflected in the sink by a deflector roll,